All posts by: Michael Zand

About Michael Zand

‘Stem cell tourism’ pushing patients towards unproven procedures – Genetic Literacy Project

Continue reading

2015-11-18

Stem cell tourism’ pushing patients towards unproven procedures
Genetic Literacy Project
Stem cell scientists appear to have oversold their product. In debates a decade ago, scientists, foundations and patient advocacy groups spoke glibly of cures for chronic diseases which would come after embryonic stem cell research was legalised.

Continue reading

2015-11-18

Martin: Republicans should discuss stem cell research
Journal Times
Living in Wisconsin, we are lucky to have the University of Wisconsin-Madison Stem Cell and Regenerative Medicine Center being an industry leader in the world and this important research having the ability to someday cure Parkinson’s disease, leukemia, …

Continue reading

2015-11-18

Daily Mail

‘If you’re not afraid, then it’s not painful’: Brave 13-year-old boy donates
Daily Mail
A 13-year-old boy has warmed the hearts of the nation after the story of his bravery was shared by Chinese media. Kong Decheng has offered to undergo several grueling procedures to donate stem cells in a bid to save his father, Kong Lingjun, who was …

Continue reading

2015-11-18

Daily Californian

Campus researchers uncover unique properties of key stem cell factor
Daily Californian
A team of UC Berkeley researchers presented the first-ever structural model of a protein factor believed to play a crucial role in the expression of the defining genes in embryonic stem cells. The team’s research, published Monday in the scientific

Continue reading

2015-11-17

Seeking Alpha

Stem Cell Company Cesca Therapeutics’ Bad Idea
Seeking Alpha
So can we go back and help me, listening to the company, listening to the programs, listening to the dynamics associated with SurgWerks. You know that I’m a believer and we really believe that this point-of-care model has a role in cell therapy space

Continue reading

2015-11-17

Seeking Alpha

Stem Cell Company Cesca Therapeutics’ Bad Idea
Seeking Alpha
So can we go back and help me, listening to the company, listening to the programs, listening to the dynamics associated with SurgWerks. You know that I’m a believer and we really believe that this point-of-care model has a role in cell therapy space